Boston Scientific Corp. has announced it has received FDA approval and market launch of its Epic vascular self-expanding stent system, according to a news release. Boston Scientific said the Epic ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Boston Scientific Corp. (NYSE: BSX) of Natick said Thursday ...
NATICK, Mass. (AP) -- Medical device maker Boston Scientific Corp. said Thursday it received U.S. approval for a new type of stent to treat blocked arteries in the legs. The Food and Drug ...